The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study—a study protocol for a randomized controlled trial

BACKGROUND: Age-related macular degeneration (AMD) is an irreversible blinding eye condition with complex genetic and environmental etiologies. Genetic testing for AMD for previously identified multiple-risk single nucleotide polymorphisms can help determine an individual’s future susceptibility. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Addo, Emmanuel K., Hartnett, M. Elizabeth, Bernstein, Paul S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278319/
https://www.ncbi.nlm.nih.gov/pubmed/37337222
http://dx.doi.org/10.1186/s13063-023-07436-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278319/
https://www.ncbi.nlm.nih.gov/pubmed/37337222
http://dx.doi.org/10.1186/s13063-023-07436-4

Ejemplares similares